Google DeepMind, AI and Demis Hassabis

AI-developed drug will be in trials by year-end, says Google’s Hassabis
Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its parent company, Alphabet. The start-up’s potential has attracted big pharmaceutical partners, which are keen to lower expenses and boost efficiency of the costly drug development process.
Trials of drugs developed with AI could begin this year, Google DeepMind CEO says
The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.
DeepMind’s Hassabis Sees AI-Designed Drug Trials This Year
Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this year, according to its Nobel Prize-winning chief executive officer.
Wall Street Lunch: AI-Designed Drugs Expected To See Trials This Year
Google's DeepMind spinoff Isomorphic Labs expects clinical trials of drugs designed using AI to start late this year.
DeepMind expects clinical trials for AI-designed drugs this year
Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this year, according to its Nobel Prize-winning chief executive officer. “We’ll hopefully have some AI-designed drugs in clinical trials by the end of the year,
CNET on MSN6h
Galaxy S25 Phones First to Feature Google's Project Astra AI Tech
The Samsung Galaxy S25 will be the first family of phones to include Google's Project Astra, the companies announced ...
Trump Pushes to Make US an AI Superpower, With Fewer Guardrails
In his first 24 hours back in Washington, Donald Trump sent a different message to the AI community: Just build. On Monday, ...
Chase your passions, go deep with them: AI pioneer Demis Hassabis on what his dad and S’pore-born mum told him
He tells Sumiko Tan how he spent long summers in Singapore as a child with his Singapore-born mum. Read more at ...
Google releases free Gemini 2.0 Flash Thinking model, pressuring OpenAI’s premium strategy
Google challenges OpenAI with free Gemini 2.0 Flash Thinking model, offering million-token processing, native code execution, and breakthrough performance in math and science benchmarks.
Google's DeepMind eyes clinical trials for AI-designed drugs in 2025 - report
Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year.
Why Drug Developers That Utilize AI, Including SDGR and RXRX, Are Jumping
Pharmaceutical firms that specialize in utilizing AI to speed up the drug discovery process are soaring today.
BI Davos Diary: How Meta is trying to reassure advertisers about its big makeover
In a Davos roundtable discussion with BI, Nicola Mendelsohn, head of Meta's global business group, said the company had been ...
Hosted on MSN19h
Google DeepMind CEO says 2025's the year we start popping pills AI helped invent
Nobel Prize winner Demis Hassabis thinks human trials will happen soon Clinical trials of the first drugs designed with the ...